Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

BACKGROUND: Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim to develop a generalized, individualized immune prognostic signature that can stratify and predict overall survival for ovarian cancer. METHODS: The gene expression profiles of ovarian cancer tumor tissue sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Sipeng, Wang, Guanrong, Zhang, Ruyang, Zhao, Yang, Yu, Hao, Wei, Yongyue, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412087/
https://www.ncbi.nlm.nih.gov/pubmed/30594555
http://dx.doi.org/10.1016/j.ebiom.2018.12.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412087/
https://www.ncbi.nlm.nih.gov/pubmed/30594555
http://dx.doi.org/10.1016/j.ebiom.2018.12.054

Ejemplares similares